Merck scraps disappointing experimental cholesterol drug

FILE - In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck's decision Wednesday, Oct. 11, 2017, to not seek regulatory approval after years of testing marks the fourth time this type of once-promising drug has been scrapped. (AP Photo/Mel Evans, File)

TRENTON, N.J. — Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results.

Merck's decision Wednesday to not seek regulatory approval after years of testing marks the fourth time this type of once-promising drug has been scrapped. Merck had continued to study its drug, a so-called CETP inhibitor called anacetrapib, long after rivals had given up on similar drugs.

Merck raised hopes when it announced in June that anacetrapib not only lowered cholesterol, but also reduced heart attacks, deaths and other heart disease complications. But in August it disclosed the pill only cut those risks 9 percent.

That would have limited sales of the drug, if it had won regulatory approval, in part because cheap, genetic statin drugs lower cholesterol well for most people.

Must Read

MS-13 gang targeted in pre-dawn sweep across Los Angeles

May 17, 2017

Hundreds of federal and local law enforcement fanned out across Los Angeles in pre-dawn sweeps, serving arrest and search warrants as part of a three-year investigation into the violent street gang MS-13

NHL poised to skate into China, hockey's next frontier

Mar 27, 2017

The NHL is poised to skate into China, hockey's next frontier

Army schedules hearing to consider Bowe Bergdahl plea

Oct 12, 2017

The Army has scheduled a hearing next week for Bowe Bergdahl to enter an expected guilty plea to charges that he endangered comrades by walking off his remote post in Afghanistan in 2009

People also read these

MS-13 gang targeted in pre-dawn sweep across Los Angeles

May 17, 2017

Hundreds of federal and local law enforcement fanned out across Los Angeles in pre-dawn sweeps, serving arrest and search warrants as part of a three-year investigation into the violent street gang MS-13

NHL poised to skate into China, hockey's next frontier

Mar 27, 2017

The NHL is poised to skate into China, hockey's next frontier

Army schedules hearing to consider Bowe Bergdahl plea

Oct 12, 2017

The Army has scheduled a hearing next week for Bowe Bergdahl to enter an expected guilty plea to charges that he endangered comrades by walking off his remote post in Afghanistan in 2009